Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma.

MLA

Wisdom, Amy J., et al. “Rationale and Emerging Strategies for Immune Checkpoint Blockade in Soft Tissue Sarcoma.” Cancer (0008543X), vol. 124, no. 19, Oct. 2018, pp. 3819–29. EBSCOhost, https://doi.org/10.1002/cncr.31517.

APA

Wisdom, A. J., Mowery, Y. M., Riedel, R. F., & Kirsch, D. G. (2018). Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma. Cancer (0008543X), 124(19), 3819–3829. https://doi.org/10.1002/cncr.31517

Chicago

Wisdom, Amy J., Yvonne M. Mowery, Richard F. Riedel, and David G. Kirsch. 2018. “Rationale and Emerging Strategies for Immune Checkpoint Blockade in Soft Tissue Sarcoma.” Cancer (0008543X) 124 (19): 3819–29. doi:10.1002/cncr.31517.